Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response
Background: Respiratory syncytial virus (RSV) is a poor inducer of antiviral interferon (IFN) responses which result in incomplete immunity and RSV disease. Several RSV proteins alter antiviral responses, including the non-structural proteins (NS1, NS2) and the major viral surface proteins, that is,...
Main Authors: | Harrison C. Bergeron, Lawrence M. Kauvar, Ralph A. Tripp |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-03-01
|
Series: | Therapeutic Advances in Infectious Disease |
Online Access: | https://doi.org/10.1177/20499361231161157 |
Similar Items
-
RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
by: Harrison C. Bergeron, et al.
Published: (2022-10-01) -
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
by: Harrison C. Bergeron, et al.
Published: (2023-04-01) -
Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies
by: Harrison C. Bergeron, et al.
Published: (2021-02-01) -
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge
by: Thomas J. Powell, et al.
Published: (2022-12-01) -
Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease
by: Patricia A. Jorquera, et al.
Published: (2015-10-01)